Scott Rodgers

Scott Rodgers joined Immunomic Therapeutics in July 2020. He has over 22 years of increasing experience contributing to, leading, and developing clinical operation departments focused on clinical development strategy, clinical operations, sponsor oversight and project management. Mr. Rodgers has experience in study start-up, conduct, and closeout of approximately thirty-five Phase I-IV studies in vaccines, drugs, biologics and devices across a wide range of therapeutic areas and patient populations (pediatric, adult, vulnerable population) including infectious diseases, cardiology, oncology, gene therapy, neurology, rare and ultra-rare diseases. Mr. Rodgers is proficient with building quality management systems, developing departmental infrastructure (SOPs, eTMF, training programs), and leading experienced teams to enable ICH-GCP and FDA regulation compliance from design and execution throughout the clinical development phases.

Prior to joining ITI, Mr. Rodgers worked for Leadiant Biosciences as Senior Director Clinical Operations. He has also worked in previous increasing roles of responsibility within clinical operations positions at various organizations including NIH, various CROs, and Sponsor companies.

Mr. Rodgers earned his Master of Science degree from Louisiana State University in Veterinary Sciences, Veterinary Microbiology and Parasitology and his Bachelor of Science degree from Shepherd University majoring in Biology and minoring in Chemistry. Additionally, he has earned certifications as a clinical research associate (CCRA) and project manager (ACRP-PM) from Association of Clinical Research Professionals (ACRP).